For physicians

Decades in the making, Barricaid is the only FDA-approved device designed to close large defects in the annulus. Barricaid allows you to preserve more of your patient’s disc while reducing their risk of reherniation and reoperation. A Level I RCT (randomized controlled trial) of 554 patients showed an approximate 50% reduction in reherniation and reoperative recurrence starting at the 90-day mark and running through 5 years post-surgery.

The lose-lose of large annular defects

Research shows that a big hole is a big problem when it comes to discectomy. Large annular defects have been linked to significant rates of reherniation and reoperation. Repeat surgery for such patients can have a significant impact on surgical outcomes, opioid use, and nonworking status5,6,8 — bad outcomes for you and for the patients you are trying to help

Beating the odds of reherniation and reoperation

The Barricaid implant is designed to provide you with a superior intraoperative choice for patients with large annular defects. The procedure is straightforward—measure the annular defect, test Barricaid alignment, then anchor and confirm Barricaid positioning under fluoroscopy. The benefit to your patients is significant and enduring. With Barricaid, you significantly improve the odds of a more durable outcome for discectomy surgery.


  1. O’Donnell JA et al. Treatment of Recurrent Lumbar Disc Herniation With or Without Fusion in Workers’ Compensation Subjects. Spine 2017
  2. Ahn J et al. Primary versus Revision Single-level Minimally Invasive Lumbar Discectomy. Spine 2015
  3. Leven D, Passias PG, Errico TJ, et al. Risk Factors for Reoperation in Patients Treated Surgically for Intervertebral Disc Herniation: A Subanalysis of Eight-Year SPORT Data. J Bone Joint Surg Am. 2015;97(16):1316-1325; and

If Barricaid is right for you, we can help.

Sign up to receive future updates and information on the Barricaid procedure.
  • This field is for validation purposes and should be left unchanged.

WordPress Lightbox Plugin